Blueprint Medicines Corp AAAAI Call Transcript
Ladies and gentlemen, thank you for standing by, and welcome to Blueprint Medicines conference call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions)
I would now like to hand the conference over to your speaker today, Kristin Hodous of Blueprint Medicines. Thank you. Please go ahead, ma'am.
Thank you, operator. Good morning, everyone, and thank you for joining us today to review the updated clinical data for avapritinib in indolent systemic mastocytosis. You can access the press release for the avapritinib data as well as the slides that we'll be reviewing today by going to the Investors section of our website at www.blueprintmedicines.com.
With me today are Jeff Albers, our Chief Executive Officer; Dr. Andy Boral, our Chief Medical Officer; Dr. Brenton Mar, our Senior Medical Director and Clinical Lead for the avapritinib program in
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |